Keywords: مسدود کننده های گیرنده آنژیوتانسین II; ACC; American College of Cardiology; AHA; American Heart Association; ADHF; Acute decompensated heart failure; BNP; Brain natriuretic peptide; ACEi; Angiotensin-converting enzyme inhibitors; ARB; Angiotensin II receptor blockers; ARNI; Angiotensin recepto
مقالات ISI مسدود کننده های گیرنده آنژیوتانسین II (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; Type 2 diabetes; Hypertension; Sulfonylureas; Calcium channel blockers; Angiotensin II receptor blockers;
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; Sleep duration; Workdays; Nonworkdays; Cardiac-cerebral vascular diseases; China; MI; myocardial infarction; SJL; social jetlag; HT; hypertension; ACEI; angiotensin-converting enzyme inhibitors; ARB; angiotensin II receptor blockers; CHD; coronary heart
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; ACE; angiotensin converting enzyme; ARBs; angiotensin II receptor blockers; AT1; angiotensin II receptor type-1; AT2; angiotensin II receptor type-2; CCBs; calcium channel-blockers; CKD; chronic kidney disease; CysA; cyclosporine A; ERAs; endothelin recep
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; AF; atrial fibrillation; SR; sinus rhythm; ICU; intensive care unit; APACHE II; Acute Physiology and Chronic Health Evaluation II; SAPSII; Simplified Acute Physiology Score II; OR; odds ratio; CI; confidence interval; ACE; angiotensin converting enzyme; A
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; PHC; primary health care; CPG; Clinical Practice Guidelines; RCTs; randomized clinical trials; EHR; electronic health records; SIDIAP-Q; Information System for the Development of Research in Primary Care- Quality; BP; blood pressure; HbA1c; glycated haemo
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; ARNI; angiotensin II receptor blockers; ejection fraction; heart failure; neprilysin inhibitors;
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; ABPM; ambulatory blood pressure monitoring; ACEi; angiotensin converting enzyme inhibitors; ARB; angiotensin II receptor blockers; BMI; body mass index; BP; blood pressure; CKD; chronic kidney disease; CRF; case-report form; ENTRED; Echantillon National T
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; alcohol; cardiomyopathy; heart failure; prognosis; ACEI; angiotensin-converting enzyme inhibitors; ACM; alcoholic cardiomyopathy; ARB; angiotensin II receptor blockers; CG; electrocardiogram; COPD; chronic obstructive pulmonary disease; CPHM; Cox proporti
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; CVD; cardio vascular disease; UAE; urinary albumin excretion; BMI; body mass index; ACE; angiotensin-converting enzyme; ARB; angiotensin II receptor blockers; ANOVA; analysis of variance; SBP; systolic blood pressure; CI; confidence interval; CCB; calcium
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; ACEI; angiotensin converting enzyme inhibitor; ARB; angiotensin II receptor blockers; ASD; atrial septal defect; CI; confidence interval; ECG; electrocardiography; HR; hazard ratio; LV; left ventricular; Pd; P-wave dispersion; Qp/Qs ratio; ratio of pulmon
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; AF; atrial fibrillation; MetS; metabolic syndrome; DM; diabetes mellitus; LAD; left atrial diameter; LVEF; left ventricular ejection fraction; ARB; angiotensin II receptor blockers; ACEI; angiotensin-converting enzyme inhibitor; LRAF; late recurrence of A
Carotid intima-media thickness and anti-hypertensive treatment: Focus on angiotensin II receptor blockers
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; Carotid intima-media thickness; Ultrasonography; Antihypertensive drugs; Angiotensin II receptor blockers;
Comparison of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with diabetes mellitus and non-ST-segment elevation myocardial infarction who underwent successful percutaneous coronary intervention
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; Angiotensin-converting-enzyme inhibitors; Angiotensin II receptor blockers; Diabetes mellitus; Myocardial infarction; Non-ST-Segment elevation myocardial infarction;
Cost-benefit effectiveness of angiotensin-II receptor blockers in patients with uncomplicated hypertension: A comparative analysis
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; Angiotensin II receptor blockers; Cost-effectiveness; Hypertension; Outpatients; Sartans;
Use of ACE-inhibitors and falls in patients with Parkinson's disease
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; ACE-inhibitors; Angiotensin II receptor blockers; Falls; Parkinson's disease; Elderly;
Summary of the 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; CVD; cardiovascular disease; HER2; human epidermal growth factor receptor 2; HF; heart failure; T-DM1; trastuzumab, pertuzumab, trastuzumab-emtansine; TKI; lapatinib; LV; left ventricular; ACE; angiotensin-converting enzyme (ACE) inhibitors; VEGF; vascula
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers reduced dementia risk in patients with diabetes mellitus and hypertension
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; Angiotensin-converting enzyme inhibitors; Angiotensin II receptor blockers; Diabetes mellitus; Hypertension; Dementia;
Association between plasma soluble RAGE and renal function is unaffected by medication usage and enzymatic antioxidants in chronic kidney disease with type 2 diabetes
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; CKD; chronic kidney disease; D-CKD; diabetic CKD; ND-CKD; non-diabetic CKD; DM; diabetic patients without CKD; Non-DM; patients without diabetes and CKD; eGFR; estimated glomerular filtration rate; GPx; glutathione peroxidase; SOD; superoxide dismutase; R
Targeting the ROS-HIF-1-endothelin axis as a therapeutic approach for the treatment of obstructive sleep apnea-related cardiovascular complications
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; Obstructive sleep apnea; Cardiovascular disease; Intermittent hypoxia; Oxidative stress; Hypoxia inducible factor-1; Endothelin-1; AHI; apnea-hypopnea index; ARBs; angiotensin II receptor blockers; BP; blood pressure; CAD; coronary artery disease; CamK;
Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on major adverse cardiac events in patients with newly diagnosed type 2 diabetes: A nationwide study
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; Angiotensin-converting enzyme inhibitors; Angiotensin II receptor blockers; Diabetes; Major adverse cardiac events; Epidemiology;
Differential effects of angiotensin II receptor blockers on Aβ generation
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; ARBs; angiotensin II receptor blockers; AD; Azheimer's disease; Aβ; amyloid β-protein; AT1a; angiotensin type 1a receptor; ACE; angiotensin converting enzyme; MEFs; mouse embryonic fibroblasts; hAPP695; human 695-amino acid amyloid precursor protein; AP
Genotoxic evaluation of five Angiotesin II receptor blockers: In vivo and in vitro micronucleus assay
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; Angiotensin II receptor blockers; Genotoxicity; Micronuclei; FISH
Renoprotective effect of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in advanced chronic kidney disease
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; angiotensin-converting enzyme inhibitors; angiotensin II receptor blockers; chronic kidney disease; pentoxifylline; renal outcome
Mechanisms of food protein-derived antihypertensive peptides other than ACE inhibition
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; Antihypertensive peptides; Renin; Angiotensin II receptor blockers; Calcium channel blockers; Arginine-nitric oxide; Endothelin converting enzyme;
Treatment with telmisartan/rosuvastatin combination has a beneficial synergistic effect on ameliorating Th17/Treg functional imbalance in hypertensive patients with carotid atherosclerosis
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; Angiotensin II receptor blockers; Statin; Anti-inflammation; Synergistic effect; Hypertension; Atherosclerosis;
Design, synthesis and biological evaluation of new 5-nitro benzimidazole derivatives as AT1 antagonists with anti-hypertension activities
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; RAS; rennin-angiotensin system; AII; angiotensin II; ARBs; angiotensin II receptor blockers; FDA; US Food and Drug Administration; DMAP; 4-(dimethylamino)pyridine; NMR; nuclear magnetic resonance; HRMS; high-resolution mass spectrometry; ESI; electrospr
Long-term use of angiotensin II receptor blockers and risk of cancer: A population-based cohort analysis
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; Angiotensin II receptor blockers; Risk of cancer; Cohort study;
A Cost-Effectiveness Analysis between Amlodipine and Angiotensin II Receptor Blockers in Stroke and Myocardial Infarction Prevention among Hypertension Patients in China
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; amlodipine; angiotensin II receptor blockers; China; cost-effectiveness; hypertension; irbesartan;
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; angiotensin II receptor blockers; candesartan; hypertension; therapeutic interchange
Resistive index as a predictor of acute kidney injury caused by an angiotensin converting enzyme inhibitor or angiotensin II receptor blocker in chronic kidney disease patients
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; Acute kidney injury; Angiotensin converting enzyme inhibitors; Angiotensin II receptor blockers; Diuretics; Duplex Doppler ultrasonography
Endothelial nitric oxide synthase gene polymorphisms and renal responsiveness to RAS inhibition therapy in type 2 diabetic Asian Indians
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; eNOS polymorphisms; ACE inhibitors; Angiotensin II receptor blockers; Type 2 diabetes mellitus; Albuminuria
Diferencias y similitudes entre inhibidores de la enzima de conversión de la angiotensina y antagonistas de los receptores de la angiotensina II
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; Sistema renina-angiotensina-aldosterona; Hipertensión arterial; Antagonistas de los receptores de angiotensina II; Enzima de conversión de la angiotensina; Renin-angiotensin-aldosterone system; Hypertension; Angiotensin II receptor blockers; Angiotensin
Possibilities of influencing the myocardial remodeling
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; Chronic heart failure; Myocardial remodeling; Angiotensin-converting enzyme inhibitors; Angiotensin II receptor blockers; Beta-blockers; Spironolactone; Eplerenone; Ivabradine; Cardiac resynchronization therapy; Left ventricular assist devices;
Association Between Obesity and Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Operations: A Systematic Review and Meta-Analysis
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; ACE; angiotensin-converting enzyme; AF; atrial fibrillation; ARBs; angiotensin II receptor blockers; BMI; body mass index; BSA; body surface area; CABG; coronary artery bypass grafting; CAD; coronary artery disease; CHF; congestive heart failure; CI; conf
Effect of Sitagliptin on Blood Pressure and Estimated Glomerular Filtration Rate in Diabetic Patients Using an Angiotensin II Receptor Blocker
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; angiotensin II receptor blockers; blood pressure; dipeptidyl peptidase-IV inhibitors; glomerular filtration rate; type 2 diabetes mellitus
The discovery of new potent non-peptide Angiotensin II AT1 receptor blockers: A concise synthesis, molecular docking studies and biological evaluation of N-substituted 5-butylimidazole derivatives
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; Synthesis; Angiotensin II receptor blockers; N-substituted 5-butylimidazole derivatives; Antihypertensive activity; Molecular dockingB(Oi-Pr)3, triisopropyl borate; n-BuLi, n-butyllithium; t-BuOK, potassium tert-butoxide; Et3N, triethylamine; LTMP, lithiu
Reduction in 28 Days and 6 Months of Acute Myocardial Infarction Mortality From 1995 to 2005. Data From PRIAMHO I, II and MASCARA Registries
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; ACEI; angiotensin-converting enzyme inhibitor; ARB-II; angiotensin II receptor blockers; BB; betablockers; CICU; cardiac intensive care unit; GCP; guidelines on clinical practice; STEMI; ST-segment elevation acute myocardial infarction; Acute myocardial i
Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; Brain angiotensin; Angiotensin II receptor blockers; Innate immune response; Brain ischemia; Neuroprotection; Aging; Anxiety
Candesartan attenuates fatty acid-induced oxidative stress and NAD(P)H oxidase activity in pancreatic β-cells
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; Angiotensin II receptor blockers; Pancreatic β-cells; Oxidative stress; PKC; NAD(P)H oxidase activities
The Role of the Renin-Angiotensin System in the Regulation of Erythropoiesis
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; Angiotensin II; erythropoiesis; anemia; angiotensin-converting enzyme inhibitors; angiotensin II receptor blockers; hypertension; heart failure; chronic kidney disease; chronic obstructive lung disease; dialysis; kidney transplantation; post-transplant er
Intensive Versus Conventional Therapy to Slow the Progression of Idiopathic Glomerular Diseases
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; Idiopathic glomerular diseases; chronic kidney disease; proteinuria; angiotensin-converting enzyme (ACE) inhibitors; angiotensin II receptor blockers; statins; aldosterone antagonists;
Telmisartan attenuates fatty-acid-induced oxidative stress and NAD(P)H oxidase activity in pancreatic β-cells
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; Angiotensin II receptor blockers; Pancreatic β cells; Oxidative stress; PKC; NAD(P)H oxidase activityInhibiteurs des récepteurs de l’angiotensine II; Cellules β pancréatiques; Lipotoxicité; Stress oxydant; PKC; NAD (P) H oxydase
Statins, ACE inhibitors and ARBs in cardiovascular disease
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; statin; angiotensin II receptor blockers; angiotensin-converting enzyme inhibitors; inflammation
Increased inflammatory biomarkers in hypertensive type 2 diabetic patients: improvement after angiotensin II type 1 receptor blockade
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; Cytokines; chemokines; adhesion molecules; angiotensin II receptor blockers; beta blockers; glycosylated hemoglobin; blood pressure
Determinants for the adoption of angiotensin II receptor blockers by general practitioners
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; The Netherlands; Angiotensin II receptor blockers; Antihypertensive treatment; Decision making; Drug utilization; Primary care
Renin-Angiotensin System Modulation: The Weight of Evidence
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; Cardiovascular risk; angiotensin-converting enzyme inhibitors; angiotensin II receptor blockers;
Add-on and withdrawal effect of pravastatin on proteinuria in hypertensive patients treated with AT1 receptor blockers
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; angiotensin II receptor blockers; endothelin-1; hypertension; pravastatin; proteinuria;
Mechanisms for the Clinical Benefits of Angiotensin II Receptor Blockers
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; Renin-angiotensin-aldosterone system; angiotensin II receptor blockers; receptors; angiotensin antagonists and inhibitors; antihypertensive agents; pharmacology;
Prevalence of tinnitus in patients withhypertension and the impact of different anti hypertensive drugs on the incidence of tinnitus: A prospective, single-blind, observational study
Keywords: مسدود کننده های گیرنده آنژیوتانسین II; tinnitus; hypertension; diuretics; angiotensin II receptor blockers; α-blockers; 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors;